Literature DB >> 26705391

C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis.

Lin Lu1, Rui Yan Zhang2, Xiao Qun Wang1, Zhu Hui Liu2, Ying Shen2, Feng Hua Ding2, Hua Meng2, Ling Jie Wang1, Xiao Xiang Yan1, Ke Yang2, Hai Bo Wang2, Li Jin Pu2, Qi Zhang2, Qiu Jing Chen3, Raffaele De Caterina4, Wei Feng Shen5.   

Abstract

AIMS: We investigated the association of the adipokine C1q/TNF-related protein (CTRP) 1 with coronary artery disease (CAD), and the biological vascular effects of CTRP1. METHODS AND
RESULTS: We analysed CTRP1 levels in sera of CAD patients (n = 451) and non-CAD controls (n = 686), and in coronary endarterectomy specimens (n = 32), non-atherosclerotic internal mammary arteries (n = 26), aortic atherosclerotic plaques (n = 15), and non-atherosclerotic aortic samples (n = 10). C1q/TNF-related protein-levels were higher in sera, endarterectomy specimens, aortic atherosclerotic plaques, and peripheral blood mononuclear cells (PBMCs) from CAD patients compared with controls, and were related to CAD severity. The production of CTRP1 was profusely induced by inflammatory cytokines and itself caused a concentration-dependent expression of adhesion molecules and inflammatory markers in human endothelial cells, human peripheral blood monocytes, and THP-1 cells. C1q/TNF-related protein-1 induced p38-dependent monocyte-endothelium adhesion in vitro and the recruitment of leucocytes to mesenteric venules in C57BL/6 mice. Immunohistochemistry of atherosclerotic femoral arteries exhibited CD68 and VE-cadherin loci-associated increased CTRP1 expression in plaques. Compared with saline, intraperitoneal injection of recombinant CTRP1 protein (200 μg/kg) every other day promoted atherogenesis in apoE(-/-) mice at 24 weeks. However, pro-atherogenic effects were significantly attenuated in CTRP1(-/-)/apoE(-/-) double-knockout mice compared with apoE(-/-) mice, with a consistent decrease in vascular adhesion molecule, phospho-p38 and TNF-α expression and macrophage infiltration in plaque in CTRP1(-/-) and double-knockout mice. Tumour necrosis factor-α-induced expression of adhesion molecules and cytokines were lower in primary endothelial cells and macrophages from CTRP(-/-) mice than in those from C57BL/6 mice.
CONCLUSION: C1q/TNF-related protein-1 is a marker of atherosclerosis in humans and promotes atherogenesis in mice. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Adipokines; Atherosclerosis; CTRP1; Coronary artery disease; Endothelium

Mesh:

Substances:

Year:  2015        PMID: 26705391     DOI: 10.1093/eurheartj/ehv649

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

1.  C1q and TNF related protein 1 regulates expression of inflammatory genes in vascular smooth muscle cells.

Authors:  Dough Kim; Seung-Yoon Park
Journal:  Genes Genomics       Date:  2018-11-24       Impact factor: 1.839

2.  Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.

Authors:  Siqi Feng; Ya Su; Li Luo; Fengchuan Jing; Qijian Yi
Journal:  Pediatr Res       Date:  2018-05-09       Impact factor: 3.756

3.  C1q/TNF-Related Proteins, HIV and HIV-Associated Factors, and Cardiometabolic Phenotypes in Middle-Aged Women.

Authors:  Michal Kasher Meron; Shuo Xu; Marshall J Glesby; Qibin Qi; David B Hanna; Kathryn Anastos; Robert C Kaplan; Jorge R Kizer
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-03       Impact factor: 2.205

4.  Loss of CTRP1 disrupts glucose and lipid homeostasis.

Authors:  Susana Rodriguez; Xia Lei; Pia S Petersen; Stefanie Y Tan; Hannah C Little; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-23       Impact factor: 4.310

5.  Myonectin deletion promotes adipose fat storage and reduces liver steatosis.

Authors:  Hannah C Little; Susana Rodriguez; Xia Lei; Stefanie Y Tan; Ashley N Stewart; Ageline Sahagun; Dylan C Sarver; G William Wong
Journal:  FASEB J       Date:  2019-04-19       Impact factor: 5.191

Review 6.  CTRP family in diseases associated with inflammation and metabolism: molecular mechanisms and clinical implication.

Authors:  Huan Zhang; Zi-Yin Zhang-Sun; Cheng-Xu Xue; Xi-Yang Li; Jun Ren; Yu-Ting Jiang; Tong Liu; Hai-Rong Yao; Juan Zhang; Tian-Tian Gou; Ye Tian; Wang-Rui Lei; Yang Yang
Journal:  Acta Pharmacol Sin       Date:  2022-10-07       Impact factor: 7.169

7.  Aging and chronic high-fat feeding negatively affect kidney size, function, and gene expression in CTRP1-deficient mice.

Authors:  Susana Rodriguez; Hannah C Little; Parnaz Daneshpajouhnejad; Paride Fenaroli; Stefanie Y Tan; Dylan C Sarver; Michael Delannoy; C Conover Talbot; Sandeep Jandu; Dan E Berkowitz; Jennifer L Pluznick; Avi Z Rosenberg; G William Wong
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-10-21       Impact factor: 3.619

8.  Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction.

Authors:  Mariko Asada; Tomoaki Morioka; Yuko Yamazaki; Yoshinori Kakutani; Reina Kawarabayashi; Koka Motoyama; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masanori Emoto; Masaaki Inaba
Journal:  J Diabetes Res       Date:  2016-12-14       Impact factor: 4.011

9.  Data on the expression and role of TREM-1 in the development of in-stent restenosis.

Authors:  Fang Wang; Chang Li; Feng Hua Ding; Ying Shen; Jie Gao; Zhu Hui Liu; Jia Wei Chen; Rui Yan Zhang; Wei Feng Shen; Xiao Qun Wang; Lin Lu
Journal:  Data Brief       Date:  2017-11-22

10.  Late-onset renal hypertrophy and dysfunction in mice lacking CTRP1.

Authors:  Susana Rodriguez; Hannah C Little; Parnaz Daneshpajouhnejad; Blythe D Shepard; Stefanie Y Tan; Andrew Wolfe; Muhammad Umar Cheema; Sandeep Jandu; Owen M Woodward; C Conover Talbot; Dan E Berkowitz; Avi Z Rosenberg; Jennifer L Pluznick; G William Wong
Journal:  FASEB J       Date:  2019-12-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.